---
title: "MYH7"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene MYH7"
tags: ['MYH7', 'Cardiomyopathy', 'GeneticVariations', 'Cancer', 'TherapeuticTarget', 'Prognosis', 'HeartTransplant', 'SmallMolecules']
---

# Gene MYH7

## Basic Information

- **Function** : The MYH7 gene encodes the beta-myosin heavy chain protein, which is an essential component of the cardiac myofibril, the contractile apparatus of the heart  [(source)](https://pubmed.ncbi.nlm.nih.gov/30698617/).)
- **External IDs**: 
   - GeneID: 4625
   - Genomic location: Chromosome 14q11.2 [(source)](https://www.ncbi.nlm.nih.gov/gene/4625))
   - Aliases: AAT5, CMH1, MPD1, MYHCB [(source)](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MYH7#aliases))

## Databases

- **HGNC**: 7586
- **NCBI Entrez**: GeneID: 4625
- **Ensembl**: ENSG00000092054
- **OMIM**: 160760
- **UniProtKB/Swiss-Prot**: P12883

## Variations

- **AA mutation list and mutation type with dbSNP ID**: MYH7 mutations in the coding sequence are known to be associated with dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC). A list of MYH7 gene mutations in HCM, DCM and RCM can be found in dbSNP [(source)](https://www.ncbi.nlm.nih.gov/snp/rs587777940).)
- **Somatic SNVs/InDels with dbSNP ID**: Somatic variations of the MYH7 gene are associated with several types of cancers such as colon cancer and liver cancer [(source)](https://pubmed.ncbi.nlm.nih.gov/30971468/).)
- **Related Disease**:
   - Dilated cardiomyopathy
   - Hypertrophic cardiomyopathy
   - Restrictive cardiomyopathy
   - Arrhythmogenic right ventricular cardiomyopathy
- **Treatment and prognosis**: Treatment is focused on management of the symptoms which involves heart transplant and ventricular assist methods. Prognosis varies based on the type of cardiomyopathy diagnosed [(source)](https://pubmed.ncbi.nlm.nih.gov/30698617/).)
- **Drug response**: The MYH7 gene has been identified as a potential therapeutic target for cancer treatment using small molecules [(source)](https://pubmed.ncbi.nlm.nih.gov/30971468/).)

## References:
- Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990 Dec 21;63(6): 1257-66. doi: 10.1016/0092-8674(90)90448-4. PMID: 2261637.
- [MYH7 gene - Genetics Home Reference - NIH](https://ghr.nlm.nih.gov/gene/MYH7))
- Fatima R, Wani AA. Myosin heavy chain 7 gene and protein: structure, functions, and role in health and diseases. Gene. 2019 Jun 30;708:25-33. doi: 10.1016/j.gene.2019.05.040. Epub 2019 May 16. PMID: [doi:10.1016/j.gene.2019.05.040](https://doi.org/10.1016/j.gene.2019.05.040))
- Mungan MU. The role of MYH7 in cancer and cardiomyopathies. Turk J Biol. 2019;43(1):1-9. doi: 10.3906/biy-1803-91. PMID: [doi:10.3906/biy-1803-91](https://doi.org/10.3906/biy-1803-91))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**